Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects

NCT01489774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Digestive System Diseases

Interventions

DRUG: Placebo
DRUG: CJ-12406

Sponsor

HK inno.N Corporation